AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Eli Lilly CEO Dave Ricks Talks Weight Loss Drugs Success
Bloomberg Talks
Intro
This chapter explores the anti-obesity drug Zepbound, highlighting its active ingredient terzepatide and the complexities of naming pharmaceuticals. The discussion extends to the wider implications of anti-obesity medications on health and societal perceptions.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode